Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model

Journal of Gastroenterology

Volumn 43, Issue 11, 2008, Pages 889-896

  Kim, Moon Young ^a   Baik, Soon Koo ^a   Park, Dong Hun ^a   Jang, Yoon Ok ^a   Suk, Ki Tae ^a   Yea, Chang Jin ^a   Lee, Il Young ^a   Kim, Jae Woo ^a   Kim, Hyun Soo ^a   Kwon, Sang Ok ^a   Cho, Mi Yun ^a   Ko, Sang Baik ^a   Chang, Sei Jin ^a   Um, Soon Ho ^b   Han, Kwang Hyub ^c  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Angiotensin converting enzyme inhibitor; Angiotensin II receptor blocker; Hepatic fibrosis; Hepatic stellate cell

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; CAPTOPRIL; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYPROLINE; IRBESARTAN; LOSARTAN; PROCOLLAGEN; RAMIPRIL; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CELL ACTIVATION; CONTROLLED STUDY; GENE EXPRESSION; HEPATIC STELLATE CELL; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER HISTOLOGY; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SPECTROPHOTOMETRY; SPRAGUE DAWLEY RAT; STELLATE CELL; WESTERN BLOTTING;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOTTING, WESTERN; COMMON BILE DUCT; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; HYDROXYPROLINE; IMMUNOHISTOCHEMISTRY; LIGATION; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SPECTROPHOTOMETRY;

EID: 56649106258     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-008-2239-9     Document Type: Article

References (31)

1. Gines P, Cardenas A, Arroyo V, Rodes J. Management of cirrhosis and ascites. N Engl J Med 2004;350:1646-1654.
2. Bedossa P, Houglum K, Trautwein C, Holstege A, Chojkier M. Stimulation of collagen alpha 1 (I) gene expression is associated with lipid peroxidation in hepatocellular injury: A link to tissue fibrosis? Hepatology 1994;19:1262-1271.
3. Friedman SL, Roll FJ, Boyles J, Bissell DM. Hepatic lipocytes: The principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci USA 1985;82:8681-8685.
4. Matsubara H, Inada M. Molecular insights into angiotensin II type 1 and type 2 receptors: Expression, signaling and physiological function and clinical application of its antagonists. Endocr J 1998;45:137-150.
5. Wilkinson SP, Williams R. Renin-angiotensin-aldosterone system in cirrhosis. Gut 1980;21:545-554.
6. Bataller R, Gines P, Nicolas JM, Gorbig MN, Garcia-Ramallo E, Gasull X, et al. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 2000;118:1149-1156.
7. Rockey D. The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin, and nitric oxide. Hepatology 1997;25:2-5.
8. Arroyo V, Bosch J, Mauri M, Ribera F, Navarro-Lopez F, Rodes J. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites. Eur J Clin Invest 1981;11:221-229.
9. Baik SK, Jo HS, Suk KT, Kim JM, Lee BJ, Choi YJ, et al. Inhibitory effect of angiotensin II receptor antagonist on the contraction and growth of hepatic stellate cells. Korean J Gastroenterol 2003;42:134-141.
10. Lee KI, Kong ID, Baik SK, Kim HS, Lee DK, Kwon SO, et al. Characteristics of potassium and calcium currents of hepatic stellate cells (ito) in rat. Yonsei Med J 2004;45:649-660.
11. Croquet V, Moal F, Veal N, Wang J, Oberti F, Roux J, et al. Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension. J Hepatol 2002;37:773-780.
12. Jonsson JR, Clouston AD, Ando Y, Kelemen LI, Horn MJ, Adamson MD, et al. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 2001;121:148-155.
13. Wei YH, Jun L, Qiang CJ. Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats. Dig Dis Sci 2004;49:1589-1594.
14. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: A new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984;65:305-311.
15. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995;19:1409-1417.
16. Issa R, Zhou X, Constandinou CM, Fallowfield J, Millward-Sadler H, Gaca MDA, et al. Spontaneous recovery from micronodular cirrhosis: Evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 2004;126:1795-1808.
17. Iredale JP, Arthur MJ. Hepatocyte-matrix interactions. Gut 1994;35:729-732.
18. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001;120:726-748.
19. Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 1994;45:1637-1647.
20. Bataller R, Sancho-Bru P, Gines P, Lora JM, Al-Garawi A, Sole M, et al. Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 2003;125:117-125.
21. Bataller R, Gines P, Nicolas JM, Gorbig MN, Garcia-Ramallo E, Gasull X, et al. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 2000;118:1149-1156.
22. Leung PS, Suen PM, Ip SP, Yip CK, Chen G, Lai PB. Expression and localization of AT1 receptors in hepatic Kupffer cells: Its potential role in regulating a fibrogenic response. Regul Pept 2003;116:61-69.
23. Kinnman N, Francoz C, Barbu V, Wendum D, Rey C, Hultcrantz R, et al. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by plateletderived growth factor during liver fibrogenesis. Lab Invest 2003;83:163-173.
24. Hahn AW, Resink TJ, Bernhardt J, Ferracin F, Buhler FR. Stimulation of autocrine platelet-derived growth factor AAhomodimer and transforming growth factor beta in vascular smooth muscle cells. Biochem Biophys Res Commun 1991;178:1451-1458.
25. Lijnen P, Petrov V. Antagonism of the renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. Methods Find Exp Clin Pharmacol 1999;21:363-374.
26. Ramos SG, Montenegro AP, Goissis G, Rossi MA. Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum-induced rat liver fibrosis. Pathol Int 1994;44:655-661.
27. Linz W, Schaper J, Wiemer G, Albus U, Scholkens BA. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: A one year study in rats. Br J Pharmacol 1992;107:970-975.
28. Venon WD, Baronio M, Leone N, Rolfo E, Fadda M, Barletti C, et al. Effects of long-term irbesartan in reducing portal pressure in cirrhotic patients: Comparison with propranolol in a randomised controlled study. J Hepatol 2003;38:455-460.
29. Mooser V, Nussberger J, Juillerat L, Burnier M, Waeber B, Bidiville J, et al. Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition. J Cardiovasc Pharmacol 1990;15:276-282.
30. Noda M, Matsuo T, Fukuda R, Ohta M, Nagano H, Shibouta Y, et al. Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure. Kidney Int 1999;56:898-909.
31. el-Dahr SS, Dipp S, Yosipiv IV, Baricos WH. Bradykinin stimulates c-fos expression, AP-1-DNA binding activity and proliferation of rat glomerular mesangial cells. Kidney Int 1996;50:1850-1855.